Mediclinic International logo

MDC - Mediclinic International Share Price

292.4p -7.4  -2.5%

Last Trade - 4:35pm

Sector
Healthcare
Size
Mid Cap
Market Cap £2.21bn
Enterprise Value £4.71bn
Revenue £2.98bn
Position in Universe 282nd / 1804
Bullish
Bearish
Unlock MDC Revenue
Momentum
Relative Strength (%)
1m +3.58%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -26.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1,977 2,107 2,749 2,876 2,932 3,083 2,950 3,110 +9.3%
-6.2 -25.1 +5.4 +74.3 -56.6 +95.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 September 2020,Mediclinic International PLC revenues decreased 7% to£1.41B. Net income decreased 86% to £15M. Revenues reflectSouthern Africa segment decrease of 32% to £317M, SouthernAfrica segment decrease of 32% to £317M, Utilization ofLicensed Beds - %-South A decrease of 27% to 51.1%. Netincome also reflects Southern Africa segment incomedecrease of 92% to £6M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for MDC
Graphical History

Revenue

MDC Revenue Unlock MDC Revenue

Net Income

MDC Net Income Unlock MDC Revenue

Normalised EPS

MDC Normalised EPS Unlock MDC Revenue

PE Ratio Range

MDC PE Ratio Range Unlock MDC Revenue

Dividend Yield Range

MDC Dividend Yield Range Unlock MDC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MDC EPS Forecasts Unlock MDC Revenue
Profile Summary

Mediclinic International plc (Mediclinic) is an international private healthcare services provider. Mediclinic is focused on providing acute-care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic’s operational divisions includes Hirslanden Switzerland, Mediclinic Southern Africa and Mediclinic Middle East. Mediclinic comprises of 77 hospitals, five sub-acute hospitals, 14 day case clinics and 22 outpatient clinics. Hirslanden Switzerland operates 17 hospitals, two day case clinics and three outpatient clinics in Switzerland with over 1900 inpatient beds. Mediclinic Southern Africa operates 53 hospitals, five sub-acute hospitals and 10 day case clinics across South Africa and three hospitals in Namibia with over 8500 inpatient beds. Mediclinic Middle East operates seven hospitals, two day case clinics and 19 outpatient clinics with over 900 inpatient beds in the United Arab Emirates.

Directors
Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated December 20, 2012
Public Since June 26, 2013
No. of Shareholders: n/a
No. of Employees: 33,140
MDC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MDC
Upcoming Events for MDC
Frequently Asked Questions for Mediclinic International
What is the Mediclinic International share price?

As of 4:35pm, shares in Mediclinic International are trading at 292.4p, giving the company a market capitalisation of £2.21bn. This share price information is delayed by 15 minutes.

How has the Mediclinic International share price performed this year?

Shares in Mediclinic International are currently trading at 292.4p and the price has moved by -26.03% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Mediclinic International price has moved by -19.17% over the past year.

What are the analyst and broker recommendations for Mediclinic International?

Of the analysts with advisory recommendations for Mediclinic International, there are there are currently 2 "buy" , 6 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Mediclinic International is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Mediclinic International next release its financial results?

Mediclinic International is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Mediclinic International dividend yield?

Mediclinic International does not currently pay a dividend.

Does Mediclinic International pay a dividend?

Mediclinic International does not currently pay a dividend.

When does Mediclinic International next pay dividends?

Mediclinic International does not currently pay a dividend.

How do I buy Mediclinic International shares?

To buy shares in Mediclinic International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Mediclinic International?

Shares in Mediclinic International are currently trading at 292.4p, giving the company a market capitalisation of £2.21bn.

Where are Mediclinic International shares listed? Where are Mediclinic International shares listed?

Here are the trading details for Mediclinic International:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: MDC
What kind of share is Mediclinic International?

Based on an overall assessment of its quality, value and momentum, Mediclinic International is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Mediclinic International share price forecast 2021?

Shares in Mediclinic International are currently priced at 292.4p. At that level they are trading at 11.5% discount to the analyst consensus target price of 330.40.

Analysts covering Mediclinic International currently have a consensus Earnings Per Share (EPS) forecast of 0.11717 for the next financial year.

How can I tell whether the Mediclinic International share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mediclinic International. Over the past six months, the relative strength of its shares against the market has been -6.17%. At the current price of 292.4p, shares in Mediclinic International are trading at 8.53% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Mediclinic International PE Ratio?

The Mediclinic International PE ratio based on its reported earnings over the past 12 months is 20.85. The shares are currently trading at 292.4p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Mediclinic International?

Mediclinic International's management team is headed by:

Danie Meintjes - NED
Jan Durand - NED
James Alan Grieve - NID
Jurgens Myburgh - CFO
Dirk Le Roux - CIO
David Hadley - CEX
Gert Hattingh - OTH
Ronnie van der Merwe - CEO
Koert Pretorius - CEX
Felicity Harvey - NID
Muhadditha Al Hashimi - NID
Magnus Oetiker - CHO
Rene Toua - OTH
Daniel Liedtke - CEX
Dame Beale - CHM
Who are the major shareholders of Mediclinic International?

Here are the top five shareholders of Mediclinic International based on the size of their shareholding:

Remgro Ltd Holding Company
Percentage owned: 44.56% (328.5m shares)
Public Investment Corporation (SOC) Limited Sovereign Wealth Fund
Percentage owned: 9.65% (71.2m shares)
Genesis Investment Management, LLP Investment Advisor/Hedge Fund
Percentage owned: 4.99% (36.8m shares)
Statens Pensjonsfond Utland Mutual Fund
Percentage owned: 1.97% (14.5m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 1.82% (13.4m shares)
Similar to MDC
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.